Back to User profile » Dr Jin Lei
Papers published by Dr Jin Lei:
Impact of Type of Lenvatinib Resistance on Prognosis and Second-Line Regimen in Patients with Virus-Associated HCC
Zhang Y, Lei J, Ma H, Zuo S
Journal of Hepatocellular Carcinoma 2024, 11:1507-1517
Published Date: 8 August 2024
Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma
Lei J, Yang S, Chen B, Zhang L, Yan T, Yang G, Chen Y, Li Y, Lu Y, Zuo S
Journal of Hepatocellular Carcinoma 2023, 10:357-367
Published Date: 2 March 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study
Chen B, Zhang L, Cheng J, Wu T, Lei J, Yang X, Zhang R, Safadi R, Li Y, Si T, Lu Y
Drug Design, Development and Therapy 2022, 16:4429-4437
Published Date: 28 December 2022
Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective Study
Chen B, Lei J, Zhao H, Dong J, Zeng Z, Li Y, Yu L, Zhou L, Jia A, Lu Y, Cheng J
Journal of Hepatocellular Carcinoma 2022, 9:1171-1185
Published Date: 8 November 2022